Akunjalo i-FDA evunyelweyo
I-Ampligen (i-rintatolimod) kwi-test anti-viral, i-immun system-modulating drug that's been in the work for over 30 years. Kuye kwafundwa njengendlela yokwenza unyango kwiimeko ezininzi, kubandakanya ukugula okungapheliyo (i-CFS okanye i- ME / CFS ), i- HIV / AIDS , iintlobo ezithile zomhlaza , zombini umkhuhlane we-avi kunye nomkhuhlane wengulube (H1N1) kunye ne-virus ye- Ebola .
Ngo-2009 kwaye kwakhona ngo-2013, i-FDA yamlahla i-Ampligen njengonyango lwe-ME / CFS.
Bekungayi kuba yonyango lokuqala oluvunyiweyo le meko kunye nokunika ukungena kuka-Ampligen kwindawo yokuthengisa. Nangona ezi zintsilelo, umenzi uyaqhubeka nokuhamba phambili ukuze afumane le chiza.
I-Ampligen isebenza njani?
I-Ampligen ikholelwa ukuba isebenza ngokuxhuma-ukuqala indlela yomzimba wokhuselo lwe-virus kunye nokulawula amazinga e- RNase L (into ekhoyo kwiiseli ezihlasela iintsholongwane), ezinokuphakama kubantu abane-ME / CFS. Kuye kwaboniswa ukuba ivimbele ukukhula kwetomyhula ye-tumor.
U-Ampligen akabonakali ukukhusela isistim somzimba. Kunoko, kukholwa ukuba utshintshe indlela osebenza ngayo isistim somzimba wakho.
Ampligen yeSyndine Syndrome
Kwizilingo zekliniki, i-Ampligen iboniswe ukuphucula ukuqonda, ukunyamezela, ukunyamezela, impilo ye-neuropsychological kunye nomsebenzi jikelele kubantu abane-ME / CFS; ukunciphisa umsebenzi weHHV-6 (intsholongwane ekholelwa ukuba idibene ne-ME / CFS), kwaye iyancipha umsebenzi weRNase L.
Ngokomenzi we-Ampligen, i-Hemispherx Biopharma Inc., i-Ampligen engaphezu kwama-40,000 yanikwa izigulane ezingama-500 kwizilingo zeclini kwiii-klinikhi ezingama-20 zase-US. Enye yale kliniki, i-Hunter-Hopkins Centre, ithi 80% yezigulane zayo ziphuculwe kwi-Ampligen, kwaye i-50% iphuculwe kakhulu.
Ngenxa yokuba i-Ampligen ayivunyelwe okwangoku nayiphi na indlela e-US, kuphela iiklinikhi ezineemfuno ezikhethekileyo zingenza i-Ampligen. Kwakhona kudibanisa kakhulu-njengokuba kungaphezu kwama-40,000 ngonyaka! Yaye akukho, i-inshurensi yakho ayiyi kugubungela, kuba iyayilinga.
I-Ampligen nayo ihlala ingavunyelwanga kwiYurophu yaseYurophu, kodwa ezinye izigulane zilapho ziyakwazi ukufumana oko kubizwa ngokuthi "inkqubo yokufikelela kwangaphambili."
Ampligen Isisombululo
I-Ampligen ilawulwa nge-intravenously (IV). Kwizilingo kunye nangemvume evumelekileyo yi-FDA, izigulane ziye zafumana u-400mg weziyobisi kabini ngeveki. U-Hunter-Hopkins uncoma ubuncinane iinyanga ezili-12 zonyango kunye neenyanga ezili-18 zokugula kakhulu.
Ampligen Side Effects
Njengawuphi na iziyobisi, i-Ampligen inokubangela iziphumo ezingathandekiyo. Iziphumo ezichaphazelekayo ziquka:
- Ukunyanzelisa,
- Ukuqina kwesifuba,
- Intliziyo yokukhawuleza,
- Ukukhathazeka,
- Ukuqhawukelwa ngumphefumlo,
- Ndivakalelwa sishushu,
- Ukukrokra,
- I sizathu,
- Ishintsho se-enzyme yesibindi,
- Uhudo,
- Ukutshiza,
- Uxinzelelo lwegazi oluphantsi,
- Rash,
- Arrhythmias,
- Inani elisezantsi lamhlophe yegazi,
- Utywala,
- Ukudideka.
Ezinye izigulane zinempawu ezinjengeentsholongwane emva kweeyure ezimbalwa emva kokufumana umthamo weziyobisi. Umenzi uthi le miphumo iyahamba emva kweenyanga ezininzi zonyango.
Imithombo:
Smith ME, et al. Amanqaku angamayeza angaphakathi. 2015 Juni 16; 162 (12): 841-50. Unyango lwe-myalgic encephalomyelitis / chronic fatigue syndrome: ukuhlaziywa ngokuchanekileyo kwiZiko leSizwe lezeMpilo kwiNkqubo yokuVikela ukuVimbela.
Strayer DR, et al. PLoS One. 2012; 7 (3): e31334. I-double-blind-controlled, placebo-elawulwayo, i-randomized, i-clinical trial of TLR-3 i-rintatolimod kwiimeko ezinzima zesifo esingapheliyo.
Strayer DR, et al. Izifo ezithathelwanayo. Ngo-1994 uJan; 18 Isibonelelo 1: S88-95. Uvavanyo lwekliniki olulawulwayo kunye nesilwanyana esilungeleleneyo seRNA, i-poly (I) .poly (C12U), kwi-syndrome engapheliyo.
Suhadolnik RJ, et al. In vivo. 1994 Julayi-Aug; 8 (4): 599-604. Utshintsho kwi-2-5A sythetase / RNase L yindlela yokuvimbela i-anti-virus kwimeko yesilingo elawulwayo kunye ne-poly (I) -poly (C12U) kwi-syndrome engapheliyo.